AUM $1.04BER 0.36%NAV $114.97Holdings 26Inception Dec 2011
Price Chart
Key Statistics
Previous Close
$117.87Day Range
$115.82$117.49
52-Week Range
$85.99$117.87
Avg Volume
210.8KDividend Yield
1.71%Expense Ratio
0.36%AUM
$1.04BShares Outstanding
8.7METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 62.25% |
| United Kingdom | 10.89% |
| Switzerland | 10.10% |
| Denmark | 5.13% |
| France | 4.03% |
| Israel | 3.24% |
| Japan | 3.06% |
| Ireland | 1.16% |
| Canada | 0.12% |
| Other | 0.02% |
Fund Information
- Issuer
- VanEck
- Category
- Healthcare
- Types
- Pharma
- Inception Date
- Dec 20, 2011
- Exchange
- NASDAQ
- Description
- VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
Similar ETFs
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund issued by VanEck that launched on Dec 20, 2011. It currently manages $1.04B in assets under management. The fund charges an expense ratio of 0.36%. The fund holds 26 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 73.3% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 20.16% | 167,746 | $214.8M |
| 2 | MRK | Merck & Co Inc | 10.89% | 761,971 | $116.0M |
| 3 | NVS | Novartis Ag | 10.15% | 674,273 | $108.1M |
| 4 | PFE | Pfizer Inc | 4.93% | 1,861,461 | $52.6M |
| 5 | BMY | Bristol-Myers Squibb Co | 4.90% | 771,366 | $52.2M |
| 6 | NVO | Novo Nordisk A/S | 4.86% | 1,113,156 | $51.7M |
| 7 | ABBV | Abbvie Inc | 4.51% | 180,802 | $48.1M |
| 8 | JNJ | Johnson & Johnson | 4.38% | 170,523 | $46.6M |
| 9 | MCK | Mckesson Corp | 4.35% | 54,257 | $46.3M |
| 10 | GSK | Gsk Plc | 4.16% | 838,151 | $44.3M |
| 11 | SNY | Sanofi Sa/France | 4.02% | 933,417 | $42.8M |
| 12 | AZN | Astrazeneca Plc | 3.52% | 227,265 | $37.5M |
| 13 | COR | Cencora Inc | 3.51% | 117,943 | $37.4M |
| 14 | TEVA | Teva Pharmaceutical Industries Ltd | 3.16% | 897,625 | $33.6M |
| 15 | TAK | Takeda Pharmaceutical Co Ltd | 3.07% | 1,781,664 | $32.7M |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -1.59% | |
| 1W | +2.46% | |
| 1M | +4.20% | |
| 3M | +9.72% | |
| 6M | +3.84% | |
| YTD | +11.83% | |
| 1Y | +30.75% | |
| 3Y | +40.90% | |
| 5Y | +52.80% |
Moving Averages
20-Day MA
$112.50
Above 20-Day MA50-Day MA
$110.04
Above 50-Day MA200-Day MA
$105.04
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$117.87
Current Price
$115.99
52-Week Low
$85.99
$85.99$117.87
Current Yield
1.71%
Annual Dividend
$2.1726
Frequency
4x/year
Last Ex-Date
Jul 1, 2026
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Jul 1, 2026 | $0.6248 | Jul 7, 2026 |
| Apr 1, 2026 | $0.8441 | Apr 7, 2026 |
| Dec 29, 2025 | $0.3106 | Dec 31, 2025 |
| Oct 1, 2025 | $0.3931 | Oct 6, 2025 |
| Jul 1, 2025 | $0.6069 | Jul 7, 2025 |
| Apr 1, 2025 | $0.5245 | Apr 4, 2025 |
| Dec 27, 2024 | $0.4110 | Dec 30, 2024 |
| Oct 1, 2024 | $0.4090 | Oct 4, 2024 |
| Jul 1, 2024 | $0.3558 | Jul 5, 2024 |
| Apr 1, 2024 | $0.5328 | Apr 5, 2024 |
| Dec 27, 2023 | $0.3074 | Dec 29, 2023 |
| Oct 2, 2023 | $0.3398 | Oct 6, 2023 |
| Jul 3, 2023 | $0.3891 | Jul 7, 2023 |
| Apr 3, 2023 | $0.6641 | Apr 10, 2023 |
| Dec 28, 2022 | $0.2400 | Dec 30, 2022 |
| Oct 3, 2022 | $0.2700 | Oct 7, 2022 |
| Oct 3, 2022 | $0.2696 | Oct 7, 2022 |
| Jul 1, 2022 | $0.2500 | Jul 8, 2022 |
| Jul 1, 2022 | $0.2496 | Jul 8, 2022 |
| Apr 1, 2022 | $0.4430 | Apr 7, 2022 |
Dividend Payments Over Time
Category Comparison
| Metric | PPH | Healthcare(223 ETFs) | Pharma(29 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.36% | 0.62% | 0.66% |
| AUM | $1.04B | $1.98B | $1.78B |
| Dividend Yield | 1.71% | 3.90% | 1.82% |
| Avg Volume | 210.8K | 422.1K | 408.5K |
| Holdings | 26 | 167 | 39 |
| Performance | |||
| 1-Month Return | +6.77% | +6.56% | +8.31% |
| 6-Month Return | +12.37% | +16.09% | +23.36% |
| YTD Return | +14.25% | +16.75% | +23.65% |
| 1-Year Return | — | +15.10% | +26.72% |
Compare with Another ETF
Search for an ETF to compare with PPH:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.